BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 17119028)

  • 1. A meta-analysis of diabetes mellitus and the risk of prostate cancer.
    Kasper JS; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2056-62. PubMed ID: 17119028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
    Larsson SC; Orsini N; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(22):1679-87. PubMed ID: 16288121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.
    Bansal D; Bhansali A; Kapil G; Undela K; Tiwari P
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):151-8, S1. PubMed ID: 23032360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies.
    Park CH; Myung SK; Kim TY; Seo HG; Jeon YJ; Kim Y;
    BJU Int; 2010 Sep; 106(6):762-9. PubMed ID: 20590551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis.
    Bonovas S; Peponis V; Filioussi K
    Diabet Med; 2004 Jun; 21(6):609-14. PubMed ID: 15154948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis.
    Schulze MB; Schulz M; Heidemann C; Schienkiewitz A; Hoffmann K; Boeing H
    Arch Intern Med; 2007 May; 167(9):956-65. PubMed ID: 17502538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
    Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Takkouche B; Regueira-Méndez C; Etminan M
    J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Each portion of fruit or vegetable consumed halves the risk of oral cancer.
    Conway DI
    Evid Based Dent; 2007; 8(1):19-20. PubMed ID: 17380179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis.
    Tian T; Zhang LQ; Ma XH; Zhou JN; Shen J
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):217-23. PubMed ID: 22187293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.
    Bonovas S; Filioussi K; Sitaras NM
    Am J Gastroenterol; 2008 Oct; 103(10):2646-51. PubMed ID: 18684187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective reporting biases in cancer prognostic factor studies.
    Kyzas PA; Loizou KT; Ioannidis JP
    J Natl Cancer Inst; 2005 Jul; 97(14):1043-55. PubMed ID: 16030302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
    Larsson SC; Giovannucci E; Bergkvist L; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2561-4. PubMed ID: 17164387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and risk of prostate cancer: a meta-analysis.
    Bonovas S; Filioussi K; Tsantes A
    Diabetologia; 2004 Jun; 47(6):1071-8. PubMed ID: 15164171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.